Author: "E.S. Antonarakis" - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"E.S. Antonarakis"' showing total 8 results

Start Over Author "E.S. Antonarakis"

8 results on '"E.S. Antonarakis"'

1. KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)

Author: R. McDermott, J.N. Graff, E.S. Antonarakis, C.J. Hoimes, S.T. Tagawa, C. Hwang, D. Kilari, A.J.T. Tije, A. Omlin, U.N. Vaishampayan, A. Elliott, H. Wu, J. Kim, C. Schloss, and J.S. De Bono
Subjects: Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published: 2020
Full Text: View/download PDF

2. Pembrolizumab (pembro) for docetaxel-pretreated metastatic Castration-Resistant Prostate Cancer (mCRPC): Update on KEYNOTE-199, cohorts 1-3

Author: J.M. Piulats, E.S. Antonarakis, M. Gross-Goupil, J.C. Goh, U.N. Vaishampayan, R. De Wit, T. Alanko, S. Fukasawa, K. Tabata, S. Feyerabend, R. Berger, H. Wu, J. Kim, C. Schloss, and J.S. De Bono
Subjects: Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published: 2020
Full Text: View/download PDF

3. 1362MO Pembrolizumab + olaparib vs abiraterone (abi) or enzalutamide (enza) for patients (pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC): Randomized open-label phase III KEYLYNK-010 study

Author: E.Y. Yu, S.H. Park, J.C.H. Goh, S.J. Shin, N. Mehra, R. McDermott, M.A. Sala Gonzalez, P.C. Fong, R. Greil, M. Retz, J.P. Sade, Y-H. Huang, S. Begbie, F. Rey, G. Kramer, H. Suzuki, J. Zhang, J. Kim, C.H. Poehlein, and E.S. Antonarakis
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

4. 1365P The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)

Author: S. Gupta, Q. Yang, S. Halabi, A. Tubbs, Y. Gore, D.J. George, D.M. Nanus, E.S. Antonarakis, D. Danila, R. Szmulewitz, R.J. Wenstrup, and A.J. Armstrong
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

5. 1373P SPOP mutations (mtSPOP) are a treatment-selection biomarker in patients (pts) with de novo metastatic castration-sensitive prostate cancer (dn-mCSPC)

Author: U. Swami, R.P. Graf, R. Nussenzveig, V. Fisher, H. Tukachinsky, G. Li, N. Sayegh, N. Tripathi, V. Mathew Thomas, G.R. Oxnard, E.S. Antonarakis, and N. Agarwal
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

6. 1364MO Preliminary phase II results of the CYPIDES study of ODM-208 in metastatic castration-resistant prostate (mCRPC) cancer patients

Author: K. Fizazi, A. Bernard-Tessier, P. Barthelemy, T. Utriainen, G. Roubaud, A. Flechon, J.C.M. van der Voet, G. Gravis Mescam, R. Ratta, R.H. Jones, O.A. Parikh, M.M.E. Tanner, C. Garratt, L. Nevalaita, P. Pohjanjousi, T. Ikonen, E.S. Antonarakis, and N. Cook
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

7. 1387P Final analysis of the phase Ib/II study of sabizabulin in men with metastatic castration-resistant prostate cancer who progressed on an androgen receptor targeting agent

Author: M.C. Markowski, M. Eisenberger, C. Pieczonka, D. Rodriguez, K.G. Barnette, R.H. Getzenberg, M.S. Steiner, D.R. Saltzstein, E.S. Antonarakis, and R.F. Tutrone
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

8. VERU-111, a novel oral inhibitor of α and β tubulin, inhibits tumor growth in the human castration-resistant AR variant prostate cancer (PCa) model 22Rv1

Author: R. Getzenberg, M.M. Markowski, M.A. Eisenberger, M.S. Steiner, and E.S. Antonarakis
Subjects: Urology
Published: 2019
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results